🚀 VC round data is live in beta, check it out!

Azenta Valuation Multiples

Discover revenue and EBITDA valuation multiples for Azenta and similar public comparables like Eckert & Ziegler, Vazyme Biotech, CareDx, Daan Gene and more.

Azenta Overview

About Azenta

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.


Founded

1978

HQ

United States

Employees

3.0K

Website

azenta.com

Financials (LTM)

Revenue: $610M
EBITDA: $76M

EV

$798M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Azenta Financials

Azenta reported last 12-month revenue of $610M and EBITDA of $76M.

In the same LTM period, Azenta generated $281M in gross profit, $76M in EBITDA, and $30M in net income.

Revenue (LTM)


Azenta P&L

In the most recent fiscal year, Azenta reported revenue of $594M and EBITDA of $66M.

Azenta expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Azenta forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$610MXXX$594MXXXXXXXXX
Gross Profit$281MXXX$270MXXXXXXXXX
Gross Margin46%XXX46%XXXXXXXXX
EBITDA$76MXXX$66MXXXXXXXXX
EBITDA Margin12%XXX11%XXXXXXXXX
EBIT Margin4%XXX3%XXXXXXXXX
Net Profit$30MXXX$23MXXXXXXXXX
Net Margin5%XXX4%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Azenta Stock Performance

Azenta has current market cap of $1B, and enterprise value of $798M.

Market Cap Evolution


Azenta's stock price is $25.04.

See Azenta trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$798M$1B0.0%XXXXXXXXX$0.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Azenta Valuation Multiples

Azenta trades at 1.3x EV/Revenue multiple, and 10.6x EV/EBITDA.

See valuation multiples for Azenta and 15K+ public comps

EV / Revenue (LTM)


Azenta Financial Valuation Multiples

As of April 20, 2026, Azenta has market cap of $1B and EV of $798M.

Equity research analysts estimate Azenta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Azenta has a P/E ratio of 38.0x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$798MXXX$798MXXXXXXXXX
EV/Revenue1.3xXXX1.3xXXXXXXXXX
EV/EBITDA10.6xXXX12.1xXXXXXXXXX
EV/EBIT31.9xXXX49.4xXXXXXXXXX
EV/Gross Profit2.8xXXX3.0xXXXXXXXXX
P/E38.0xXXX49.2xXXXXXXXXX
EV/FCF18.5xXXX20.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Azenta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Azenta Margins & Growth Rates

Azenta's revenue in the last 12 month grew by 6%.

Azenta's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Azenta's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Azenta's rule of X is 27% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Azenta and other 15K+ public comps

Azenta Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth6%XXX5%XXXXXXXXX
EBITDA Margin12%XXX11%XXXXXXXXX
EBITDA Growth26%XXX26%XXXXXXXXX
Rule of 40—XXX19%XXXXXXXXX
Bessemer Rule of X—XXX27%XXXXXXXXX
Revenue per Employee—XXX$0.2MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
R&D Expenses to Revenue5%XXX5%XXXXXXXXX
Opex to Revenue—XXX49%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Azenta Public Comps

See public comps and valuation multiples for other Laboratory Services and Diagnostics & Genomics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
AzentaXXXXXXXXXXXXXXXXXX
Eckert & ZieglerXXXXXXXXXXXXXXXXXX
Vazyme BiotechXXXXXXXXXXXXXXXXXX
CareDxXXXXXXXXXXXXXXXXXX
Daan GeneXXXXXXXXXXXXXXXXXX
NeoGenomicsXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Azenta M&A Activity

Azenta acquired XXX companies to date.

Last acquisition by Azenta was on XXXXXXXX, XXXXX. Azenta acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Azenta

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Azenta Investment Activity

Azenta invested in XXX companies to date.

Azenta made its latest investment on XXXXXXXX, XXXXX. Azenta invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Azenta

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Azenta

When was Azenta founded?Azenta was founded in 1978.
Where is Azenta headquartered?Azenta is headquartered in United States.
How many employees does Azenta have?As of today, Azenta has over 3K employees.
Who is the CEO of Azenta?Azenta's CEO is John P. Marotta.
Is Azenta publicly listed?Yes, Azenta is a public company listed on Nasdaq.
What is the stock symbol of Azenta?Azenta trades under AZTA ticker.
When did Azenta go public?Azenta went public in 1995.
Who are competitors of Azenta?Azenta main competitors are Eckert & Ziegler, Vazyme Biotech, CareDx, Daan Gene.
What is the current market cap of Azenta?Azenta's current market cap is $1B.
What is the current revenue of Azenta?Azenta's last 12 months revenue is $610M.
What is the current revenue growth of Azenta?Azenta revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Azenta?Current revenue multiple of Azenta is 1.3x.
Is Azenta profitable?Yes, Azenta is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Azenta?Azenta's last 12 months EBITDA is $76M.
What is Azenta's EBITDA margin?Azenta's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Azenta?Current EBITDA multiple of Azenta is 10.6x.
What is the current FCF of Azenta?Azenta's last 12 months FCF is $43M.
What is Azenta's FCF margin?Azenta's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Azenta?Current FCF multiple of Azenta is 18.5x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial